Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review

Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review

Increasing evidence suggests that the gut microbiome is associated with both cancer chemotherapy (CTX) outcomes and adverse events (AEs). This review examines the relationship between the gut microbiome and CTX as well as the impact of CTX on the gut microbiome. A literature search was conducted in...

Full description

Bibliographic Details
Main Authors: Byeongsang Oh, Frances Boyle, Nick Pavlakis, Stephen Clarke, Alex Guminski, Thomas Eade, Gillian Lamoury, Susan Carroll, Marita Morgia, Andrew Kneebone, George Hruby, Mark Stevens, Wen Liu, Brian Corless, Mark Molloy, Towia Libermann, David Rosenthal, Michael Back
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
gut microbiome
chemotherapy
cancer
biomarker
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.706331/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.706331/full

Similar Items